Pharmaceutical Technology ePT Weekly:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile
ePT by PharmTech logo
News
Company Notes
PharmTech,
the magazine
Product Spotlight
People Notes
Regulatory Roundup
Equipment & Processing Report

 
 
 
 

 
 
 

About Us

Subscribe to Pharmaceutical Technology

Whitepaper Library

Podcasts

Webcast: Protect and Legally Defend Your Scientific Intellectual Property: Digital Signatures Alone Aren't Enough
Mar. 31, 2011—Sponsored by Surety

Webcast: Critical Path Decisions for the 4 C’s in Life Sciences: Buy, Subscribe or Outsource Your “Order to Cash”, Contracts, Chargebacks and Compliance Systems
Apr. 14, 2011—Sponsored by CDC Software

Webcast: Strategies in Bioavailability Enhancement of Poorly Permeable Small and Large Molecular Entities (BCS III & IV)
May 3, 2011—Sponsored by Evonik Degussa Corporation

Webcast: Metabolic Syndrome: Important Considerations in Trial Design
May 5, 2011 (North America) and May 10, 2011 (Europe)—Sponsored by SGS

Podcast: A conversation with Jim Greenwood

Events

WHCC 8th Annual Pharmaceutical, Biotech, and Medical Device Summit
Apr. 4–Apr. 6
Washington DC

DIA/FDA Quantitative Structure-activity Relationship (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals
Apr. 7
Rockville

Active Pharmaceutical Ingredient (API) and Drug Product Specifications
Apr. 6–Apr. 8
King of Prussia

DIA/FDA Quantitative Structure-activity Relationship (Q)SAR Approaches to Assessing Genotoxic Impurities in Pharmaceuticals
Apr. 7
Rockville

2011 PDA Annual meeting
Apr. 11–Apr.13
San Antonio

Bio IT World Conference & Expo 2011
Apr. 12–Apr.14
Boston

BioTrinity 2011
Apr. 12–Apr.14
Newbury

More events


FindPharma Search
March 24, 2011 PharmTech.com

News

Pfizer Considers Selling its Businesses
Pfizer is considering divesting some of its businesses to maximize their value, according to remarks made by Mikael Dolsten, Pfizer's president of worldwide research and development.
Click Here to Read More

EMA Sides with Former Executive Director
The European Medicines Agency Management Board gave its approval for the current activities of former executive director Thomas Lönngren. Click Here to Read More

Novartis Acquires Chinese Vaccine Company
Novartis has acquired a majority stake in Zhejiang Tianyuan Bio-Pharmaceutical, one of the largest privately held vaccine companies in China. Click Here to Read More


Product Spotlight

Rotary feeder improves conveying efficiency

The ACS Valves Aero-Flow series of rotary feeders is designed to convey pharmaceutical ingredients efficiently. Air enters the feeder through its two endplates. As the air circulates around the endplates, the air pressure increases and prevents the ingredients from getting into the feeder's seals and bearings.

Air passes through a slot in the bottom of each endplate into the feeder housing and mixes with material being conveyed by the 10-vane rotor. The feeder thus aerates the material and helps it to flow freely. The aeration also helps to keep sticky or abrasive ingredients away from the feeder housing, endplates, and rotor, thus reducing wear on the unit.

In addition, the rotor design prevents material from building up inside the feeder. The precision tolerance of the 10-vane rotor design inside the unit prevents excess air from passing through the valve.

Advertisement:
Join SSCI, A Division of Aptuit, for an educational short course on Pharmaceutical Solids: Essential Knowledge and Advanced Concepts
On April 5 & 6, 2011, Dr. Stephen R. Byrn and Scientists from SSCI will present a 2-day overview of pharmaceutical solid-state research for process chemists, engineers, materials scientists, intellectual property attorneys and pharmaceutical scientists. Location: Hyatt at The Bellevue, Philadelphia, PA. Register today at: www.aptuit.com/ItsAllAbouttheServices/service.htm

 
Company Notes

Almac’s Clinical Technologies business unit has formed an exclusive integrated patient management alliance with Exco InTouch. The alliance will be focused on the integration of both technology and processes by both firms to deliver patient management, compliance, retention, and ePRO service offerings to sponsors of clinical trials.

Almac, a contract development and manufacturing organization, has announced an investment in two ZED automated inline wallet presses in Craigavon and Pennsylvania to reduce timelines associated with the use of blister card packaging.

Boehringer Ingelheim has entered into a pact to provide MorphoSys with process development and additional manufacturing for its early clinical-stage chronic lymphocytic leukemia candidate MOR208 and other drugs. MOR208 is an in-licensed antibody currently undergoing Phase I evaluation in the US by MorphoSys’ partner Xencor.

Advertisement:
Balances Deliver Speed, Durability, Precision
Quick…and to the point! Shimadzu balances deliver the performance, functionality, and value scientists need. The unique UniBloc one-piece manufacturing assembly assures stable temperature characteristics, excellent response, and a long operational life, while Windows® Direct Communication enables easy integration of weighing results with laboratory software. Learn more...

 

Novartis has completed the transaction to acquire an 85% stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical. This acquisition provides Novartis with an expanded presence in the Chinese vaccines market and is expected to facilitate the introduction of additional Novartis vaccines into China.

Merck and sanofi-aventis have mutually terminated their agreement to form a new animal health joint venture by combining Merial, the animal health business of sanofi-aventis, with Intervet/Schering-Plough, Merck's animal health unit. As a result, each party will keep its current, separate animal health assets and businesses.

Eli Lilly and Company announced today that patients should not use the alcohol prep pads made by the Triad Group that are contained in the black starter kits for Forteo®[teriparatide (rDNA origin) injection] in the United States. The Triad Group is recalling the alcohol prep pads due to potential contamination with the bacteria, Bacillus cereus, which could result in life threatening infections, especially in at-risk populations, including immune suppressed and surgical patients.

Advertisement:
Feel the empowerment that comes from knowing that SAFC is ready to meet your contract manufacturing needs with quality products, innovative ideas and superior service. We stand ready to work with you every step of the way, anticipating your needs and offering keen insight. If you missed us at Informex, please visit our website and discover for yourself the SAFC difference. www.safcglobal.com

 

Takeda's Millenium group has extended its ADC partnership with Seattle Genetics for the global development and commercialization of brentuximab vedotin (SGN-35).

Advertisement:
At Solvay Chemicals, we manufacture BICAR® Sodium Bicarbonate and Soda Ash IPH to meet the exacting specifications of the US and EP Pharmacopeias and National Formulary. Produced according to cGMP, these are the products of choice for API or excipient applications requiring effervescent or desiccant properties. Solvay Chemicals, Inc. is part of the Solvay Group, the leading global producer of sodium bicarbonate and soda ash. http://www.solvaychemicals.us/marketsapplications/marketshidden/0,,40615-2-0,00.htm

  

Do you have news to report on facility expansions, contracts, service agreements, mergers, acquisitions, or personnel appointments? Send press releases to ptpress@advanstar.com

People Notes

Synergy has appointed Dr. Laura Barrow vice-president of clinical operations. She will be responsible for guiding Synergy's clinical programs, including the Phase II/III study for plecanatide, the company's lead drug candidate.

Valeant has named Michael Pearson, currently Valeant's chief executive officer, as chairman of the board of directors, replacing Robert A. Ingram, who remains on the Valeant board as an independent board director and lead director. Pearson will continue in his role as CEO and has agreed to extend his contract through to February 2017.

Lithera has announced the the appointment of George W. Mahaffey as president and chief executive officer. Mahaffey will also join the Lithera board of directors.

Advertisement:
Spirax Sarco Presents a Solution for the Prevention of Reverse Flow and Cross Contamination The CVS10 provides a solution to protect any item of equipment from pressure surges associated with hydraulic forces such as waterhammer. Additional features include: full traceability of wetted materials throughout the valve, .507psi (35mbar) opening pressure as standard, high kv value with minimal pressure loss, and a choice of surface finish to maintain sterility and reduce risk of microbial growth. Read more

   
Regulatory Roundup

The US Pharmacopeia (USP) is seeking scientists from around the world for its 2011-2012 fellowship program. The two $50,000 research fellowship awards will be presented to the students whose proposed research best directly addresses specific USP scientific or research needs, according to a USP notice on the program. The deadline for submissions is May 20, 2011. Full details are online at www.usp.org/aboutUSP/careers/fellowship.html

In addition to the implementation training programs ICH has been conducting around the world during the past year, the organization is now posting on its website a consolidated training package. This package covers the integrated implementation of the ICH Q8, Q9, and Q10 guidelines including details on technical development, manufacturing , pharmaceutical quality systems, and regulatory expectations (e.g., dossier preparation, assessment, and GMP-inspections), according to an ICH press release.

Advertisement:
Thousands of pharmaceutical, biologic, generic, and contract services professionals gather annually at INTERPHEX (March 29-31, 2011, Javits Convention Center, New York City) to see new products, network, and learn about emerging trends surrounding drug manufacturing. At INTERPHEX 2011, you’ll find the solutions and education you need to ensure quality, improve efficiency, and solve your manufacturing and supply chain problems. Register for a free exhibit hall pass at www.INTERPHEX.com

   
PharmTech, the magazine
Current Issue cover
Brazil Develops Its First National Plasma Fractionation Plant
Correspondent Hellen Berger provides insight into Brazil's growing pharma industry. Read the full story in the March 2011 issue.
Click Here to Read More

Coming Soon: Be sure to look for PharmTech's special April edition on solid dosage and excipients.

 
PharmTech, the magazine
Current Issue cover
The Rise of In-Line Blending
Erik Greb
Growing interest in continuous drug manufacturing has brought greater attention to in-line blending, a process that the petroleum and fine-chemicals industries have used for decades.
Click Here to Read More

 

 
 
 
 
 
 
 
 
 
 
 
 

PharmTech Poll

INTERPHEX 2011
At INTERPHEX, I will be most interested in attending sessions about?

Vote here
View the poll archive.

On Our Blog PharmTech Talk

>>Recent Posts

Biotech
Vaccines Loom Large at INTERPHEX

Asia News
Pharma Supports Earthquake Efforts In Japan

Industry conferences
Continued Focus on Continuous Processing

>>Go to the Blog Homepage

| Subscribe | Send Feedback | Advertise With Us | Visit PharmTech.com |

You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.

Visit PharmTech.com Visit PharmTech.com About Us Subscribe Today! Start your RSS subscription today! Manufacturing Outsourcing Formulation Ingredients Testing Drug Delivery IT Packaging Regulation Visit PharmTech.com